日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Translation of a Human-Based Malaria-on-a-Chip Phenotypic Disease Model for In Vivo Applications

将基于人体的疟疾芯片表型疾病模型转化为体内应用

Rupar, Michael J; Hanson, Hannah M; Botlick, Brianna L; Sriram, Narasimhan; Rogers, Stephanie; Zuniga, Justin; Liu, Zhanhe; Trimmer, Steven J; Ciurca, Joseph M; Long, Christopher J; McAleer, Christopher W; Schmidt, Stephan; Favuzza, Paola; Lowe, Philip; Gobeau, Nathalie; Hickman, James J

Circulating CXCL9, monocyte percentage, albumin, and C-reactive protein as a potential, non-invasive, molecular signature of carotid artery disease in 65+ patients with multimorbidity: a pilot study in Age.It

循环 CXCL9、单核细胞百分比、白蛋白和 C 反应蛋白作为 65 岁以上合并多种疾病患者颈动脉疾病的潜在、非侵入性分子标志物:一项发表于 Age.It 的初步研究。

Capri, Miriam; Fronterrè, Sara; Collura, Salvatore; Giampieri, Enrico; Carrino, Sara; Feroldi, Francesca Maria; Ciurca, Erika; Conte, Maria; Olivieri, Fabiola; Ullo, Ines; Pini, Rodolfo; Vacirca, Andrea; Astolfi, Annalisa; Vasuri, Francesco; La Manna, Gaetano; Pasquinelli, Gianandrea; Gargiulo, Mauro

Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up

循环 miR-122-5p、miR-92a-3p 和 miR-18a-5p 作为人类肝移植随访中的潜在生物标志物

Cristina Morsiani, Salvatore Collura, Federica Sevini, Erika Ciurca, Valentina Rosa Bertuzzo, Claudio Franceschi, Gian Luca Grazi, Matteo Cescon, Miriam Capri

Evaluation of the nanosphere verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients

使用 VersaTREK 血培养系统评估纳米球 Verigene 革兰氏阳性血培养检测方法,并评估其对特定患者的潜在影响

Beal, Stacy G; Ciurca, Jane; Smith, Geremy; John, Jeffrey; Lee, Francesca; Doern, Christopher D; Gander, Rita M